Click on image to view larger version.

Figure 5 Death (D), myocardial infarction (MI), or ischemia on Holter monitoring through 48 h. The composite event of D, MI, or ischemia on Holter monitoring through 48 h occurred in 18% of the bivalirudin arm compared with 14.2% of the pooled eptifibatide arms (odds ratio [OR] 1.35, 95% confidence interval [CI] 0.91 to 2.01, p = 0.150), whereas the composite of D or MI occurred in 8.8% and 6.6%, respectively (OR 1.37, 95% CI 0.81 to 2.31, p = 0.246). One patient in the eptifibatide arm died outside of the 48-h window (at 3 days after randomization) secondary to a retroperitoneal bleed.